Bright Minds Biosciences Inc. Cash Flow Statement

Cash Flow Statement Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024
Operating Activities
Net Income 0.03M-0.48M
Share-based Compensation 0.12M0.70M0.69M0.85M0.62M
Asset Writedowns and Impairment 0.00M
Cash from Operations 0.03M-0.21M-5.79M-10.64M-5.21M-1.36M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.00M0.05M0.05M
Change in Working Capital
Change in Receivables -0.03M0.03M
Change in Account Payables 0.08M0.40M0.60M-0.89M0.18M
Change in Accured Expenses 0.03M0.08M0.40M0.33M
Other Working Capital Changes -0.06M-0.07M0.00M0.10M-0.14M
Financing Activities
Cash from Financing Activities 0.75M20.62M4.07M1.62M0.60M
Debt Issuance and Repayment
Net Debt Issuances and Repayments 0.60M
Additional items
Exchange Rate Effect 0.18M0.20M-0.03M0.01M
Change in Cash 0.54M14.82M-6.57M-3.59M-0.76M
Free Cash Flow 0.03M-0.21M-5.79M-10.64M-5.21M-1.36M
Net Cash Flow 0.03M0.54M14.82M-6.57M-3.59M-0.76M